As a pilot analysis, we analyzed the mutational and expression profiles of 262 genes (Supplementary file 7), relevant to hematological malignancies in a cohort of 14 FLT3-ITD positive de novo AML patients (Figure 5A, panel a). Here, FLT3 is linked to acute myeloid leukemia.